According to a new report by Reports and Data, the global Fiducial Markers Market is expected to reach USD 127.3 Million by 2027. Fiducial markers are commonly used in image-guided radiotherapy procedures to help locate a tumor and provide maximum radiation dosage to the tumor while limiting radiation dose to healthy tissue nearby.

The growing prevalence of cancer is a significant factor driving the growth of the fiducial markers market. Early detection and diagnosis of cancer are crucial, and greater awareness of warning symptoms of cancer would positively impact the survival rate and hence would be instrumental in increasing the market demand. The Covid-19 pandemic has further heightened the need for fiducial markers for cancer patients, who may possess different risk profiles associated with contracting COVID-19 and the peril of complications arising out of infection from the virus.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/3471

The report finds that metal-based markers contributed to the largest fiducial markers market size in 2019 due to benefits like a high contrast level and better visualization. Ultrasound is likely to grow at a rate of 4.7% in the forecast period for the fiducial markers market due to lower toxicity associated with ionizing radiation, as well as cost-effectiveness as compared to other forms of modalities.

Lung cancer is likely to witness a growth rate of 4.8% in the forecast period for the fiducial markers market due to various reasons, including smoking, genetic, and exposure to toxic gases. The fiducial markers market in the Asia Pacific region is expected to grow at the fastest rate of 5.5% in the forecast period due to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities for diagnostic procedures, among others.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/3471

Key players in the fiducial markers market include Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies, Stellar Medical, CIVCO Radiotherapy, Medtronic, Innovative Oncology Solutions, IZI Medical Products, Nanovi A/S, and Eckert & Ziegler, among others. In December 2019, IZI Medical Products, LLC, a leading fiducial markers market player, acquired RadioMed, the producer of VISICOIL™, an implantable fiducial marker.

The report segments the global fiducial markers market on the basis of type, modalities, application, end-user, and region. By type, metal-based markers contributed to the largest fiducial markers market size in 2019, and by modalities, ultrasound is likely to grow at a rate of 4.7% in the forecast period. By cancer type, lung cancer is likely to witness a growth rate of 4.8% in the forecast period. By region, the fiducial markers market in the Asia Pacific region is expected to grow at the fastest rate of 5.5% in the forecast period.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/3471

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs